Exacerbations in chronic obstructive pulmonary disease (COPD) are major contributors to worsening lung function, impaired quality of life, emergency healthcare use and COPD-related mortality. COPD exacerbations are heterogeneous in terms of airway inflammation and aetiology. About 60% of COPD patients have blood eosinophil counts of ≥2%, which appears to be associated with an increased risk of exacerbations [1–3]. However, the association between blood eosinophil counts at stable disease and COPD exacerbations in the subsequent year is incompletely understood.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
|Titolo:||Blood eosinophil count and exacerbation risk in patients with COPD|
|Data di pubblicazione:||2017|
|Appare nelle tipologie:||03.1 Articolo su rivista|